BOSTON SCIENTIFIC CP BSX (NYSE)

(NEW YORK)Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The Food and Drug Administration approved the stent late Wednesday, a...READ MORE

(NEW YORK)Shares of medical device companies opened mixed Thursday with the broader market as the Labor Department reported that the nation's unemployment rate held steady at 5.5 percent las...READ MORE

(NEW YORK)Abbott Laboratories will reach its market share goals for its drug-coated Xience V stent, analysts said Thursday. The Food and Drug Administration approved the stent late Wednesday...READ MORE

(NORTH CHICAGO, Ill.)Drug developer and medical device maker Abbott Laboratories said Wednesday it received Food and Drug Administration approval for its anticipated drug-coated stent, Xience V.READ MORE

(NEW YORK)Shares of medical device companies closed mixed Wednesday amid a declining broader market as oil prices hit a new record and May factory orders showed the weakest performance in th...READ MORE

(NEW YORK)Moody's Investors Service said Wednesday it is reviewing ratings for Angiotech Pharmaceuticals Inc. and could possibly issue a downgrade, citing the medical product maker's negativ...READ MORE

(NEW YORK)Shares of medical device companies closed mixed Tuesday as the broader market rose on a mix of rising oil prices and more positive sales figures for General Motors and U.S. factory...READ MORE